Pecora Gabriele E, Ceccarelli Rolando, Bonelli Marco, Alexander Harold, Ricci John L
Private Practice, Rome, Italy.
Implant Dent. 2009 Feb;18(1):57-66. doi: 10.1097/ID.0b013e31818c5a6d.
A tapered dental implant (Laser-Lok [LL] surface treatment) with a 2 mm wide collar, that has been laser micromachined in the lower 1.5 mm to preferentially accomplish bone and connective tissue attachment while inhibiting epithelial downgrowth, was evaluated in a prospective, controlled, multicenter clinical trial.
Data are reported at measurement periods from 1 to 37 months postoperative for 20 pairs of implants in 15 patients. The implants are placed adjacent to machined collar control implants of the same design. Measurement values are reported for bleeding index, plaque index, probing depth, and crestal bone loss.
No statistical differences are measured for either bleeding or plaque index. At all measurement periods there are significant differences in the probing depths and the crestal bone loss differences are significant after 7 months (P < 0.001). At 37 months the mean probing depth is 2.30 mm and the mean crestal bone loss is 0.59 mm for LL versus 3.60 and 1.94 mm, respectively, for control implant. Also, comparing results in the mandible versus those in the maxilla demonstrates a bigger difference (control implant - LL) in the mean in crestal bone loss and probing depth in the maxilla. However, this result was not statistically significant.
The consistent difference in probing depth between LL and control implant demonstrates the formation of a stable soft-tissue seal above the crestal bone. LL limited the crestal bone loss to the 0.59 mm range as opposed to the 1.94 mm crestal bone loss reported for control implant. The LL implant was found to be comparable with the control implant in safety endpoints plaque index and sulcular bleeding index. There is a nonstatistically significant suggestion that the LL crestal bone retention superiority is greater in the maxilla than the mandible.
一种带有2毫米宽颈部的锥形牙种植体(激光锁定[LL]表面处理),在其下部1.5毫米处进行了激光微加工,以优先实现骨和结缔组织附着,同时抑制上皮细胞向下生长,该种植体在一项前瞻性、对照、多中心临床试验中进行了评估。
报告了15名患者中20对种植体术后1至37个月测量期的数据。种植体与相同设计的机械加工颈部对照种植体相邻放置。报告了出血指数、菌斑指数、探诊深度和嵴顶骨吸收的测量值。
出血指数或菌斑指数均未测得统计学差异。在所有测量期,探诊深度存在显著差异,7个月后嵴顶骨吸收差异显著(P<0.001)。在37个月时,LL种植体的平均探诊深度为2.30毫米,平均嵴顶骨吸收为0.59毫米,而对照种植体分别为3.60毫米和1.94毫米。此外,比较下颌骨与上颌骨的结果表明,上颌骨的平均嵴顶骨吸收和探诊深度的差异(对照种植体-LL)更大。然而,这一结果无统计学意义。
LL种植体与对照种植体在探诊深度上的持续差异表明在嵴顶骨上方形成了稳定的软组织封闭。LL将嵴顶骨吸收限制在0.59毫米范围内,而对照种植体报告的嵴顶骨吸收为1.94毫米。发现LL种植体在安全终点菌斑指数和龈沟出血指数方面与对照种植体相当。有一个无统计学意义的迹象表明,LL在上颌骨中嵴顶骨保留优势比下颌骨更大。